Healthcare provider profile · identity verified

Rex Neil Figy, M.D.

Family Practice · TOLEDO, OH · NPI 1861492357

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	365	121
Levothyroxine Sodium	Levothyroxine Sodium	233	72
Amlodipine Besylate	Amlodipine Besylate	201	66
Losartan Potassium	Losartan Potassium	189	55
Metoprolol Succinate	Metoprolol Succinate	186	62
Omeprazole	Omeprazole	182	61
Pantoprazole Sodium	Pantoprazole Sodium	154	49
Lorazepam	Lorazepam	142	38
Lisinopril	Lisinopril	139	38
Alprazolam	Alprazolam	126	38
Gabapentin	Gabapentin	122	35
Potassium Chloride	Potassium Chloride	122	30
Sertraline Hcl	Sertraline Hcl	119	33
Allopurinol	Allopurinol	117	27
Rosuvastatin Calcium	Rosuvastatin Calcium	117	40
Hydrochlorothiazide	Hydrochlorothiazide	110	34
Simvastatin	Simvastatin	108	37
Tramadol Hcl	Tramadol Hcl	106	26
Tamsulosin Hcl	Tamsulosin Hcl	102	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	32
Tizanidine Hcl	Tizanidine Hcl	97	35
Metoprolol Tartrate	Metoprolol Tartrate	92	22
Meloxicam	Meloxicam	91	24
Metformin Hcl Er	Metformin Hcl	91	31
Metformin Hcl	Metformin Hcl	85	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	23
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	79	24
Zolpidem Tartrate	Zolpidem Tartrate	77	18
Glimepiride	Glimepiride	71	22
Carvedilol	Carvedilol	69	23
Albuterol Sulfate Hfa	Albuterol Sulfate	68	18
Furosemide	Furosemide	66	24
Citalopram Hbr	Citalopram Hydrobromide	65	16
Clopidogrel	Clopidogrel Bisulfate	64	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	21
Famotidine	Famotidine	59	17
Celecoxib	Celecoxib	57	14
Escitalopram Oxalate	Escitalopram Oxalate	57	18
Fluticasone Propionate	Fluticasone Propionate	56	27
Finasteride	Finasteride	55	17
Trazodone Hcl	Trazodone Hcl	55	19
Pravastatin Sodium	Pravastatin Sodium	54	19
Spironolactone	Spironolactone	54	15
Eliquis	Apixaban	53	17
Doxazosin Mesylate	Doxazosin Mesylate	52	11
Glipizide Er	Glipizide	52	15
Januvia	Sitagliptin Phosphate	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	48	13
Atenolol	Atenolol	46	15
Montelukast Sodium	Montelukast Sodium	45	12
Ibuprofen	Ibuprofen	44	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	14
Azithromycin	Azithromycin	42	36
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Nifedipine Er	Nifedipine	41	12
Fluoxetine Hcl	Fluoxetine Hcl	40	13
Buspirone Hcl	Buspirone Hcl	37	suppressed
Lovastatin	Lovastatin	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Clonazepam	Clonazepam	33	11
Mirtazapine	Mirtazapine	33	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Topiramate	Topiramate	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	21
Bupropion Xl	Bupropion Hcl	25	suppressed
Prednisone	Prednisone	25	17
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Lactated Ringers	Ringer's Solution,lactated	24	suppressed
Magnesium Sulfate-D5w	Magnesium Sulfate/D5w	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Diazepam	Diazepam	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	11
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Estradiol	Estradiol	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Cephalexin	Cephalexin	17	14
Gemfibrozil	Gemfibrozil	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Niacin Er	Niacin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Nyamyc	Nystatin	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ozempic	Semaglutide	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Hydrocortisone	Hydrocortisone	13	11
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Colchicine	Colchicine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error